A KSHV microRNA enhances viral latency and induces angiogenesis by targeting GRK2 to activate the CXCR2/AKT pathway.
Li W, Jia X, Shen C, Zhang M, Xu J, Shang Y, Zhu K, Hu M, Yan Q, Qin D, Lee MS, Zhu J, Lu H, Krueger BJ, Renne R, Gao SJ, Lu C.
Li W, et al.
Oncotarget. 2016 May 31;7(22):32286-305. doi: 10.18632/oncotarget.8591.
Oncotarget. 2016.
PMID: 27058419
Free PMC article.